During the study period (6 months), at least, forty patients are randomly allocated into following one of two groups using sealed envelopes: remifentanil-based propofol-supplemented anesthesia regimen is employed in Group R and conventional balanced sevoflurane-sufentanil anesthesia regimen in Group C, respectively.